Login Contact Members Join Proiect Romania
AmCham Romania
Members only
Home |Privacy policy
COVID-19 Response Member Initiatives Johnson & Johnson Romania donates over half million lei to support national front-line health workers response and to protect chronic patients in the context of the COVID-19 pandemic

Johnson & Johnson Romania donates over half million lei to support national front-line health workers response and to protect chronic patients in the context of the COVID-19 pandemic

by Janssen, Johnson & Johnson Romania April 16, 2020
COVID-19 Relief Support

The funds are earmarked for the acquisition of personal protective equipment for front-line health workers, and to ensure safety for treatment continuity of chronic patients during the novel coronavirus pandemic.

Johnson & Johnson Romania commits 650,000 lei in cash donations to support the community in its response to the COVID-19 pandemic. The aid is offered through the Romanian Red Cross, the Federation of Cancer Patients Associations (FABC) and a logistics programme addressing chronic patients.

In order to support the front-line healthcare workers in their fighting of COVID-19, Johnson & Johnson Romania donates 300,000 lei to the emergency fund of the Romanian Red Cross for purchase of personal protective equipment and intensive care unit equipment. The Romanian Red Cross will coordinate with the state authorities for the distribution of the equipment.

The company responds to the call of FABC by providing 50,000 lei financial aid for the protection of the cancer patients, who, in this period, fall in the category of vulnerable people most exposed to COVID-19. In addition to the novel coronavirus threat posed to their lives, oncologic patients are endangered by the prospect of treatment cessation. For most of these patients, mainly over 60 years old, safe transportation to a hospital setting for medication administration is critical and a first step to provide this is through the PPE to be purchased by the patients’ association.

Sévan Kaloustian, Managing Director of Janssen Pharmaceutical Companies of

Johnson & Johnson Romania, said, “Our company has a long-standing history in addressing some of the world’s greatest health crises. We are, once again, facing an urgent public health crisis and it will take everyone, everywhere to dedicate efforts in order to respond and to manage it. As announced, we are providing a multi-pronged response to the pandemic which combines both our company efforts in developing our lead vaccine candidate COVID-19 as well as our endeavours to support authorities and local response in the communities we are part of. For keeping strong, it’s important to keep together.”

The endeavours of Johnson & Johnson Romania are well-advanced for developing a logistics programme, with a total investment of 300,000 lei, which is dedicated to the transportation of patients in hospital setting for a secured medication administration, in cases where this is necessary. Alternative means for administration of injectable medicines will be also made available to the patients’ in need.

In response to the COVID-19 pandemic, Johnson & Johnson is matching the individual donations of its employees worldwide, dollar to dollar, up to 1 million USD, to support the COVID-19 Solidarity Response Fund and the CDC Foundation Combat Coronavirus Campaign.


About Johnson & Johnson

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity. Learn more at www.jnj.com. Follow us at @JNJNews.


About the Janssen Pharmaceutical Companies

At Janssen, we're creating a future where disease is a thing of the past. We're the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension. Learn more at www.janssen.com. Follow us at @JanssenGlobal.

COVID-19 Relief Support

More from Member Initiatives

Previous Next